Quotient Bio Analytical Sciences was acquired by LGC on 24th December 2012. Please see the following press release for further details: LGC acquires leading bioanalytical sciences business from Quotient Bioresearch
Quotient has many years experience carrying out pharmacokinetic, pharmacodynamic and toxicokinetic studies for all stages of drug development providing expertise and quality to its clients.
Our trained and experienced pharmacokineticists use industry standard WinNonLin™ and Kinetica™ applications for non compartmental data analysis, giving you access to a complete bioanalytical pharmacokinetic/toxicokinetic (PK/TK) service to support your pre-clinical and clinical studies.
The application of PK/PD (Pharmacokinetic/pharmacodynamic) models can add further value by linking the pharmacodynamic (PD) effect to the pharmacokinetic (PK) properties of a compound and the subsequent prediction of the pharmacodynamic responses expected for differing dosage regimens.